CSIMarket
 


Intelgenx Technologies Corp   (IGXT)
Other Ticker:  
 
 

IGXT's Free Cash Flow Growth by Quarter and Year

Intelgenx Technologies 's Free Cash Flow results by quarter and year




IGXT Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -0.53 0.52 -1.47 -2.17
III Quarter September -3.74 -0.31 -4.22 -6.79
II Quarter June -2.26 -2.29 -0.01 0.89
I Quarter March -7.44 -0.25 0.63 0.09
FY   -13.97 -2.33 -5.07 -7.98



IGXT Free Cash Flow fourth quarter 2023 Y/Y Growth Comment
Intelgenx Technologies Corp in the fourth quarter 2023 recorded free cash outflow of $ -0.53 millions.

According to the results reported in the fourth quarter 2023, Intelgenx Technologies Corp achieved the best Free Cash Flow growth in Major Pharmaceutical Preparations industry. While Intelgenx Technologies Corp ' s Free Cash Flow no change of % ranks overall at the positon no. in the fourth quarter 2023.




IGXT Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - 600 % -86.76 %
FY   - - - -

Financial Statements
Intelgenx Technologies 's fourth quarter 2023 Free Cash Flow $ -0.53 millions IGXT's Income Statement
Intelgenx Technologies 's fourth quarter 2022 Free Cash Flow $ 0.52 millions Quarterly IGXT's Income Statement
New: More IGXT's historic Free Cash Flow Growth >>


IGXT Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - 888.89 %
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Intelgenx Technologies 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IGXT's IV. Quarter Q/Q Free Cash Flow Comment
Although Intelgenx Technologies Corp in the IV. Quarter 2023 showed free cash outflow of $ -0.53 millions, some analyst said, that those numbers show recovery relative to the -3.74 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Intelgenx Technologies Corp achieved highest sequential Free Cash Flow growth. While Intelgenx Technologies 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IGXT's IV. Quarter Q/Q Free Cash Flow Comment
Even if Intelgenx Technologies Corp in the IV. Quarter 2023 showed free cash outflow of $ -0.53 millions, some analyst said, that those numbers show slight up side in contrast to the -3.74 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Intelgenx Technologies Corp achieved highest sequential Free Cash Flow growth. While Intelgenx Technologies 's Free Cash Flow growth quarter on quarter, overall rank is .


Intelgenx Technologies 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Free Cash Flow 12 Months Ending $ -13.65 $ -12.57 $ -9.49 $ -9.52 $ -2.33
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Intelgenx Technologies Corp ' has realized cumulative trailing twelve months free cash outflow of $ -14 millions in the Dec 31 2023 period.
The results are getting worse as the cumulative free cash outflow is becoming larger from $ -12.57 millions in TTM ending quarter Sep 30 2023 and $ -4.32 millions for the twelve months ending in the quarter a year ago Charlotte  Johnson wrote.

Intelgenx Technologies Corp achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Intelgenx Technologies Corp ' has realized cumulative trailing twelve months free cash outflow of $ -14 millions in the Dec 31 2023 period.
The situation is getting worse as the cumulative free cash outflow is becoming larger from $ -12.57 millions for the period from Sep 30 2023 to Sep 30 2022 and $ -4.32 millions for the twelve months ending in the quarter a year ago.

Intelgenx Technologies Corp achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
IGXT's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for IGXT's Competitors
Free Cash Flow Growth for Intelgenx Technologies 's Suppliers
Free Cash Flow Growth for IGXT's Customers

You may also want to know
IGXT's Annual Growth Rates IGXT's Profitability Ratios IGXT's Asset Turnover Ratio IGXT's Dividend Growth
IGXT's Roe IGXT's Valuation Ratios IGXT's Financial Strength Ratios IGXT's Dividend Payout Ratio
IGXT's Roa IGXT's Inventory Turnover Ratio IGXT's Growth Rates IGXT's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2023
Sanofi-2.55%$ -2.546 millions
Inmode Ltd -2.62%$ -2.617 millions
Charles River Laboratories International inc -5.88%$ -5.884 millions
Mettler toledo International Inc -7.29%$ -7.291 millions
Envista Holdings Corporation-7.52%$ -7.525 millions
Bio rad Laboratories Inc -10.37%$ -10.366 millions
Inspire Medical Systems inc -10.39%$ -10.390 millions
Insulet Corporation-10.85%$ -10.848 millions
Laboratory Corporation Of America Holdings-11.32%$ -11.322 millions
Hologic Inc-13.18%$ -13.181 millions
Neurocrine Biosciences Inc -13.64%$ -13.636 millions
Gilead Sciences Inc -15.50%$ -15.504 millions
Bausch Health Companies Inc -17.89%$ -17.895 millions
Koru Medical Systems Inc-17.93%$ -17.932 millions
Progyny Inc -26.90%$ -26.900 millions
Ufp Technologies Inc -29.00%$ -28.997 millions
Enhabit Inc -29.27%$ -29.268 millions
Integra Lifesciences Holdings Corp-31.15%$ -31.153 millions
Cryoport inc -32.07%$ -32.074 millions
Qiagen N v -35.76%$ -35.764 millions
Abbvie inc -36.01%$ -36.012 millions
Regeneron Pharmaceuticals Inc -36.64%$ -36.642 millions
Pfizer Inc-38.94%$ -38.942 millions
Axonics Inc -39.81%$ -39.805 millions
Warby Parker Inc -42.68%$ -42.678 millions
Catalent Inc -47.66%$ -47.664 millions
Intuitive Surgical Inc -47.86%$ -47.865 millions
Incyte Corporation-47.92%$ -47.921 millions
Jazz Pharmaceuticals Plc-51.07%$ -51.066 millions
Edwards Lifesciences Corporation-51.70%$ -51.697 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com